Cargando…
Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo
We observed a co-upregulation of the insulin-like growth factor receptor (IGF-1R)/AKT/mammalian target of rapamycin (mTOR) [InAT] axis and the mevalonate-isoprenoid biosynthesis (MIB) pathways in colorectal cancer stem cells (CSCs) in an unbiased approach. Hence, we hypothesized that the InAT axis m...
Autores principales: | Sharon, Chetna, Baranwal, Somesh, Patel, Nirmita J., Rodriguez-Agudo, Daniel, Pandak, William M., Majumdar, Adhip PN, Krystal, Geoffrey, Patel, Bhaumik B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558155/ https://www.ncbi.nlm.nih.gov/pubmed/25895029 |
Ejemplares similares
-
Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase
por: Patel, Nirmita J., et al.
Publicado: (2016) -
Synthetic, Non-saccharide, Glycosaminoglycan Mimetics
Selectively Target Colon Cancer Stem Cells
por: Patel, Nirmita J., et al.
Publicado: (2014) -
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs †
por: Chiarella, Emanuela, et al.
Publicado: (2022) -
Five Questions about Non-Mevalonate Isoprenoid Biosynthesis
por: Odom, Audrey R.
Publicado: (2011) -
Isoprenoid biosynthesis regulation in poplars by methylerythritol phosphate and mevalonic acid pathways
por: Movahedi, Ali, et al.
Publicado: (2022)